Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study. [Clin Rheumatol. 2015]

Comment on “Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study”

Gremese, Elisa;
2016-01-01

Abstract

Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study. [Clin Rheumatol. 2015]
2016
Adalimumab
Antirheumatic Agents
Arthritis
Rheumatoid
Chemical and Drug Induced Liver Injury
Etanercept
Female
Hepatitis C
Chronic
Humans
Male
Rheumatology
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11699/85723
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 1
social impact